CleanSpace Holdings Limited

ASX:CSX Stock Report

Market Cap: AU$29.1m

CleanSpace Holdings Valuation

Is CSX undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of CSX when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate CSX's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate CSX's fair value for valuation analysis.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for CSX?

Key metric: As CSX is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for CSX. This is calculated by dividing CSX's market cap by their current revenue.
What is CSX's PS Ratio?
PS Ratio1.8x
SalesAU$15.72m
Market CapAU$29.08m

Price to Sales Ratio vs Peers

How does CSX's PS Ratio compare to its peers?

The above table shows the PS ratio for CSX vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average9.4x
AT1 Atomo Diagnostics
3.1xn/aAU$12.8m
UBI Universal Biosensors
5.1xn/aAU$35.8m
LBT LBT Innovations
28xn/aAU$35.1m
EYE Nova Eye Medical
1.5x26.3%AU$35.5m
CSX CleanSpace Holdings
1.8xn/aAU$29.1m

Price-To-Sales vs Peers: CSX is good value based on its Price-To-Sales Ratio (1.8x) compared to the peer average (9.4x).


Price to Sales Ratio vs Industry

How does CSX's PS Ratio compare vs other companies in the AU Medical Equipment Industry?

8 CompaniesPrice / SalesEstimated GrowthMarket Cap
SDI SDI
1.1x5.4%US$79.03m
SOM SomnoMed
0.6x9.0%US$34.51m
CMP Compumedics
1xn/aUS$34.05m
NXS Next Science
1.2x30.6%US$27.14m
CSX 1.8xIndustry Avg. 3.1xNo. of Companies11PS0612182430+
8 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: CSX is good value based on its Price-To-Sales Ratio (1.8x) compared to the Australian Medical Equipment industry average (3.1x).


Price to Sales Ratio vs Fair Ratio

What is CSX's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

CSX PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio1.8x
Fair PS Ration/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate CSX's Price-To-Sales Fair Ratio for valuation analysis.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.


Discover undervalued companies